Acromegaly and Cardiovascular Disease: Mechanisms, Clinical Impact, and Evolving Management

Marta Araujo-Castro1,2, Pedro Marques3, Luis Miguel Cardoso4

  • 1Endocrinology & Nutrition Department. Hospital Universitario Ramón y Cajal. Madrid, Spain.

Endocrine Reviews
|April 24, 2026
PubMed

Insights

Acromegaly significantly increases cardiovascular disease risk, impacting life expectancy. Early diagnosis and management of heart complications are crucial for improving outcomes in patients with growth hormone excess.

Area of Science:

  • Endocrinology
  • Cardiology
  • Internal Medicine

Background:

  • Acromegaly, caused by excess growth hormone and insulin-like growth factor 1, is linked to severe cardiovascular complications.
  • These complications are a primary cause of reduced life expectancy in acromegaly patients.

Purpose of the Study:

  • To review the prevalence, mechanisms, diagnosis, and management of cardiovascular complications in acromegaly.
  • To highlight the importance of early recognition and targeted treatment.

Main Methods:

  • Literature review examining cardiovascular disturbances associated with acromegaly.
  • Analysis of the impact of growth hormone and IGF-1 excess on cardiovascular health.
  • Review of diagnostic strategies and therapeutic options.

Main Results:

  • Excess GH and IGF-1 cause structural heart changes, arrhythmias, vascular dysfunction, and traditional risk factors like hypertension, diabetes, and dyslipidemia.
  • While acromegaly treatments can reverse some cardiovascular alterations, managing comorbid conditions remains vital for cardiometabolic risk.
  • Advances improve survival, but knowledge gaps persist in preventing/reversing cardiovascular damage.

Conclusions:

  • Multidisciplinary care and individualized risk assessment are essential for managing acromegaly-related cardiovascular disease.
  • Effective management requires addressing both hormonal excess and associated comorbidities.
  • Further research is needed to optimize prevention and treatment strategies.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
745
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
581
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
800